FMIBlog

Molecular Diagnostics in Pharmacogenomics Market Valuation, ROI Potential & Long-Term Growth Prospects 2026–2036

The pharmacogenomics landscape is evolving from a niche scientific pursuit to a cornerstone of value-based healthcare,” said ...
The Malaysian Reserve

Co-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies

The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...

Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
MarketWatch

Thermo Fisher Scientific Launches Industry-First, Multi-Parameter Molecular Assay for Rapid Beverage Quality Testing*

The MarketWatch News Department was not involved in the creation of this content. New Multiplex qPCR Assay developed in collaboration with Coca-Cola Europacific Partners delivers faster, broader ...
BioSpace

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA

SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ --Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of ...
KXAN

Molecular Designs Simplifies High-Risk HPV Clinical Research with New Multiplex PCR Panel

Human Papillomavirus (HPV) Simplicity Panel™ delivers a reliable, lab-ready solution for studying 14 high-risk HPV types in a streamlined research format BIRMINGHAM, Ala., Nov. 18, 2025 /PRNewswire/ - ...
Medical Xpress

Molecular test could allow for more accurate Lyme disease diagnosis

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...
360dx

Diasorin Gains FDA 510(k) Clearance for Multiplex Respiratory Test

NEW YORK – Diasorin said Friday that it has secured US Food and Drug Administration 510(k) marketing clearance for a syndromic respiratory disease test. The Saluggia, Italy-based company's Simplexa ...